These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8453485)

  • 1. Gangliosides facilitate the recovery of behavioral response mediated by dopaminergic sites following their irreversible blockade.
    Keller EA; Molina VA
    Brain Res Bull; 1993; 31(1-2):161-3. PubMed ID: 8453485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
    Mestlin M; McDougall SA
    Pharmacol Biochem Behav; 1993 Aug; 45(4):797-802. PubMed ID: 8105488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of the reversible dopamine antagonist flupenthixol are not potentiated by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in the preweanling rat.
    McDougall SA; Bolanos CA
    Pharmacol Biochem Behav; 1995 Jan; 50(1):127-31. PubMed ID: 7700948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL; Crocker AD
    Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist.
    Cameron DL; Crocker AD
    Neuroscience; 1989; 32(3):769-78. PubMed ID: 2601845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF; Waszczak BL
    Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogenetic effects of EEDQ on amphetamine-induced behaviors of rats: role of presynaptic processes.
    Crawford CA; McDougall SA; Bardo MT
    Psychopharmacology (Berl); 1994 Oct; 116(2):152-60. PubMed ID: 7862944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors.
    Lee CY; Double KL; Crocker AD
    Brain Res; 1995 May; 681(1-2):205-8. PubMed ID: 7552282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
    McDougall SA; Crawford CA; Nonneman AJ
    Psychopharmacology (Berl); 1992; 106(4):502-10. PubMed ID: 1349753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA; Rowlett JK; McDougall SA; Bardo MT
    Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade.
    Henry JM; Roth GS
    Life Sci; 1984 Aug; 35(8):899-904. PubMed ID: 6482680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats.
    Henry JM; Joseph JA; Kochman K; Roth GS
    Brain Res; 1987 Aug; 418(2):334-42. PubMed ID: 2960421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.